National Association of Testing Authorities, Australia
Scope of Accreditation
NSW Health Pathology
Site
NSW Health Pathology Liverpool Hospital Laboratory
Accreditation No.
2907
Site No.
2900
Date of Accreditation
25 May 1990
Address
NSW Health Pathology Integrated Services Building , Level 3, 1 Elizabeth Street
Liverpool, NSW 2170
Australia
Contact
Ms Wafa Jeha P: +61 (02) 98285082
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy | Formalin-fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Fixed cytological smears; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue | Detection of antigenic targets - Various |
| Molecular genetics - DNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues | DNA storage for future analyses; Viable DNA for sequencing and other molecular assays |
| Molecular genetics - DNA sequencing | Formalin-fixed paraffin-embedded (FFPE) tissues | DNA sequence analysis; Sequenced DNA utilising massively parallel sequencing technologies |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Formalin-fixed paraffin-embedded (FFPE) tissues | Solid tumours; Somatic mutation detection |
| Molecular genetics - RNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues | RNA storage for future analyses; Viable RNA for molecular diagnostics; Viable RNA for sequencing |
| Molecular genetics - RNA sequencing | Extracted RNA | RNA sequence analysis; Sequenced RNA utilising massively parallel sequencing technologies |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences; FASTQ files | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
Birthing Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Lactate |
Cardiac Catheter Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Calcium - Ionised; Carbon dioxide (CO2); Chloride; Creatinine; Glucose; Potassium; Sodium; Urea |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH |
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Total haemoglobin - Calculated |
Cardiothoracic Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Clinical Chemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Gastric aspirate; Meconium; Urine | 3,4-Methylenedioxymethamphetamine (MDMA); 3,4-Methylenedioxypyrovalerone (MDPV); Amphetamine type substances; Amphetamines; Anabolic agents; Anasthetic agents; Anti-angina agents; Anti-anxiety agents; Anti-arrythmic agents; Anti-cholinergic agents; Anti-convulsants; Anti-emetics; Anti-hypertensives; Anti-inflammatories; Anti-malarial agents; Anti-migraine agents; Anti-nauseants; Anti-psychotic agents; Anti-pyretics; Anti-rheumatoid agents; Anti-spasmodics; Anti-tussive agents; Antibiotics; Antidepressants; Antifungals; Antihistamines; Antivirals; Barbiturates; Benzodiazepines; Cannabis; Cardiovascular agents; Central nervous system agents; Chemotherapy agents; Cholelitholytics; Cholinergic agents; Cocaine; Cocaine metabolites; Decongestant agents; Diuretics; Erectile dysfunction agents; Expectorants; Glaucoma agents; Gout agents; Hyperuricemia agents; Hypoglycemic agents; Hypolipidaemic agents; Ketamine; Lysergic acid diethylamide (LSD, lysergide); Methamphetamine; Movement disorder agents; Mucolytic agents; N-Methoxybenzyl (NBOMe); Neuromuscular blocking agents; Non-steroidal anti-inflammatory drugs (NSAID); Ocular decongestants; Opiates; Opioids; Oropharyngeal agents; Paracetamol (acetaminophen); Phencyclidine; Proton pump inhibitors; Psilocybin; Pyrovalerone; Sedatives; Synthetic androgens; Synthetic cathinones; Synthetic fentanyl analogues; γ-Hydroxybutyrate (GHB) |
| Serum | Paracetamol (acetaminophen) | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Teicoplanin |
| Levetiracetam | ||
| Carbamazepine; Cyclosporin; Digoxin; Ethanol; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Paracetamol (acetaminophen); Phenytoin (dilantin); Salicylate; Tacrolimus; Valproate (valproic acid, epilim); Vancomycin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Blood | β2-Microglobulin (B2M) |
| Serum | α-Fetoprotein (AFP) | |
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Neuron specific enolase (NSE); Prostate specific antigen (PSA) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | Adrenocorticotropic hormone (ACTH); Aldosterone; C-peptide; Growth hormone; Insulin; Renin |
| Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Procalcitonin; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Serum | Fructosamine | |
| Chemical pathology - Further investigation of cardiac function | Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) |
| Creatine kinase MB (CKMB); Troponin | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Caeruloplasmin; Haptoglobins; α1-Antitrypsin |
| Uric acid | ||
| Bile acids - Quantitative | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Calcium - Ionised; Chloride; Creatinine; Glucose; Potassium; Sodium; Total carbon dioxide (TCO2); Urea |
| Blood; Cerebrospinal fluid (CSF) | Angiotensin converting enzyme (ACE) | |
| Blood; Faeces; Urine | Osmolality | |
| Cerebrospinal fluid (CSF) | Albumin; Chloride; Glucose; Lactate; Lactate dehydrogenase (LDH); Potassium; Protein - Total; Sodium | |
| Drainage fluid | Albumin; Amylase; Cholesterol - Total; Glucose; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides | |
| Peritoneal fluid | Albumin; Amylase; Cholesterol - Total; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides; Urea | |
| Pleural fluid | Albumin; Amylase; Cholesterol - Total; Glucose; Lipase; Protein - Total; Triglycerides | |
| Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase | |
| Urine | Amylase; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urea | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of maternal markers for pre-eclampsia | Serum | FMS-like tyrosine kinase 1 - Soluble; Placental growth factor (PGF, PLGF) |
| Chemical pathology - Iron studies | Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Base excess; Bicarbonate; Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH | ||
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Serum | Homocysteine |
| Chemical pathology - Quantitation of vitamins | Serum | Cobalamin (vitamin B12); Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Haemoglobin (Hb) |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Diabetes Centre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | Erythropoietin (EPO) |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH) |
| Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation | ||
| Examination of haemoglobin H (HbH) | ||
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Heinz bodies | ||
| Bone marrow | Iron | |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Detection and quantitation of foetal red cells | ||
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean corpuscular volume (MCV); Platelet count; Red blood cell distribution width (RDW); Reticulocytes |
| Differential number; Morphology | ||
| Haemopoietic progenitor cells | Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Leucocyte count (white blood cell count, WBCC); Platelet count | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Platelet aggregation | ||
| Plasma | Collagen binding activity; Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | |
| Activated partial thromboplastin time (APTT); Anti-Xa - Apixaban; Anti-Xa - Rivaroxaban; Anti-Xa activity - Low molecular weight heparin; D-dimer; Fibrinogen; International normalised ratio (INR); Mixing studies - APTT; Prothrombin time (PT); Prothrombin time (PT) mixing studies; Thrombin time (TT) | ||
| Mixing studies - APTT; Prothrombin time (PT) mixing studies; Reptilase time | ||
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Fondaparinux; Anti-Xa - Orgaran; Anti-Xa - Rivaroxaban; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Fragmin - Low molecular weight heparin; Anti-Xa activity - Heparin activity; Anti-Xa activity - Unfractionated heparin; Anti-thrombin III; D-dimer; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Plasminogen; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT) | ||
| Serum | Heparin induced thrombotic thrombocytopenia (HITT) | |
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins | ||
| Haematology - Investigation of haemolysis | Blood | Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Urine | Haemosiderin | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Fresh tissue | CD10; CD117; CD11c; CD13; CD14; CD16; CD19; CD2; CD20; CD23; CD24; CD3; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD64; CD7; CD8; HLA-DR antigen; Kappa light chains; Lambda light chains |
| Blood | Assessment of lymphoid cell populations | |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Blood; Haemopoietic progenitor cells | Enumeration of CD34+ cells |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium spp. |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood; Bone marrow | JAK2 genotyping |
| Blood borne tumours; Calreticulin; FLT3-ITD (internal tandem duplication) mutation; Nucleophosmin 1 (NPM1) mutated AML | ||
| Blood borne tumours; FLT3-TKD (tyrosine kinase domain) mutation; Isocitrate dehydrogenase IDH1 and IDH2 mutation analysis | ||
| Molecular genetics - DNA extraction | Blood; Bone marrow | DNA storage for future analyses; Viable DNA; Viable DNA for sequencing and other molecular assays |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood; Bone marrow | Quantitation of donor and recipient bone marrow derived cells in a transplant recipient |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | Haemochromatosis |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Blood | Factor V Leiden |
| Prothrombin variant |
Immunohaematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Electronic crossmatch; Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies; Immediate spin crossmatch; Indirect antiglobulin test (IAT) |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Red blood cell phenotyping |
| Antibody elution | ||
| Blood; Plasma | Other blood group antibodies; Rh | |
| Plasma | Antibody titration | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products | Antibodies; Contamination - Microbiological; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Immunopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Infliximab |
| Adalimumab | ||
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-adalimumab antibodies; Anti-cardiolipin antibodies (ACA); Anti-double stranded DNA antibodies (dsDNA); Anti-histone antibodies (AHA); Anti-infliximab antibodies; Anti-phospholipase A2 receptor antibodies (PLA2R); Anti-ribosomal P protein antibodies; Anti-β2-glycoprotein-I antibodies |
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid microsomal antibodies | ||
| Anti-adrenal cortex antibodies; Anti-endomysial antibodies (EMA); Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-pemphigoid antibodies; Anti-pemphigus antibodies; Anti-smooth muscle antibodies (SMA) | ||
| Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG) | ||
| Rheumatoid factor | ||
| Anti-extractable nuclear antigen antibodies (ENA); Anti-ribonucleoprotein antibodies (RNP) | ||
| Anti-islet cell antibodies (ICA) | ||
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Albumin |
| Oligoclonal bands; β2-Transferrin | ||
| Plasma; Serum | Cryofibrinogen; Cryoglobulins | |
| Serum | Characterisation of paraproteins; Detection and amount of paraproteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | |
| Characterisation of cryoglobulins | ||
| Detection and quantitation of free kappa and free lambda light chains | ||
| Urine | Characterisation of paraproteins; Detection and amount of paraproteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Cerebrospinal fluid (CSF) | Total immunoglobulin G |
| Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Calcium - Ionised; Carbon dioxide (CO2); Chloride; Creatinine; Glucose; Potassium; Sodium; Urea |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH | ||
| Base excess; Bicarbonate; Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH | ||
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Total haemoglobin - Calculated |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Bacteria; Pathogenic microorganisms |
| Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Respiratory specimens; Sputum; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Pathogenic microorganisms | |
| Antibiotic susceptibility; Bacteria; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Respiratory specimens; Sputum; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Urine | Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility |
| Environmental swabs | Bacterial organism identification - Acinetobacter; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Anal swab; Cervical swabs; Genital swabs; Rectal swabs; Throat swabs; Urethral swabs; Urine; Vaginal swabs | Neisseria gonorrhoeae |
| Bacterial isolates | Carbapenem resistant Enterobacteriaceae (CRE) | |
| Extended spectrum beta-lactamases (ESBL) | ||
| Pan-bacterial 16s; Van A/B/C gene | ||
| Bacterial isolates; Blood culture | Fem gene; MecA gene | |
| Blood culture; Isolates | Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA) | |
| Blood; Cerebrospinal fluid (CSF); Dry swabs | Neisseria meningitidis; Neisseria meningitidis FetA VR typing; Neisseria meningitidis PorA; Neisseria meningitidis siaD | |
| Bronchoalveolar lavage; Dry swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Bordetella pertussis; Chlamydophila pneumoniae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Cerebrospinal fluid (CSF) | Streptococcus pneumoniae | |
| Listeria monocytogenes; Neisseria meningitidis; Streptococcus pneumoniae | ||
| Eye swabs | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Faeces | Campylobacter spp.; Clostridioides difficile; Salmonella spp.; Shigella spp. | |
| Campylobacter spp.; Clostridium difficile toxin B; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp. | ||
| Rectal swabs; Throat swabs; Urethral swabs; Urine; Vaginal swabs | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Sputum | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium spp.; Dientamoeba fragilis; Entamoeba histolytica; Giardia lamblia |
| Faeces; Liver aspirate | Cryptosporidium spp.; Dientamoeba fragilis; Entamoeba histolytica; Giardia intestinalis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood; Bronchial washings; Bronchoalveolar lavage; Fresh biopsy; Plasma; Urine | Cytomegalovirus (CMV) |
| Bronchoalveolar lavage; Dry swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3; Respiratory syncytial virus (RSV) A/B; Rhinovirus | |
| Bronchoalveolar lavage; Endotrachael aspirate; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Rhinoswabs; Sputum; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Bronchoalveolar lavage; Endotrachael aspirate; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Cerebrospinal fluid (CSF); Faeces; Respiratory specimens | Enterovirus; Herpes simplex virus (HSV); Human parechovirus; Varicella zoster virus (VZV) | |
| Dry swabs | Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Faeces | Adenovirus; Norovirus G1; Norovirus G2; Rotavirus A | |
| General swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Enterovirus | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal swabs; Nasopharyngeal and throat swab | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal aspirate | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | |
| Plasma; Serum | Hepatitis C virus (HCV) viral RNA | |
| Microbiology - Molecular biology - Microbial genotyping | Serum | Hepatitis C virus (HCV) subtypes |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma | Human immunodeficiency virus (HIV) RNA viral load |
| Serum | Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Isolates | Mycobacteria identification; Other pathogenic bacteria to genus level or species level |
| Mycobacterium tuberculosis complex antigen | ||
| Sputum | Mycobacteria identification | |
| Mycobacteria identification | ||
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Nails; Skin scrapings | Yeast susceptibility |
| Fungi identification; Yeasts identification | ||
| Fungi identification; Yeasts identification | ||
| Fungi identification; Yeasts identification | ||
| Serum | Cryptococcus antigen | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody |
| Serum | Bordetella pertussis total antibody; Cytomegalovirus (CMV); Epstein-Barr virus nuclear antigen; Epstein-Barr virus; Hepatitis A virus antibody (anti-HAV) - IgM; Herpes simplex virus (HSV); Measles virus; Mumps virus; Mycoplasma pneumoniae; Parvovirus; Rubella IgG antibody; Syphilis Treponema pallidum antibody; Toxoplasma; Varicella zoster virus (VZV) | |
| Anti-streptolysin O (ASOT) | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody | ||
| Human T-lymphotropic virus type I/II (HTLV-I/II) | ||
| Dengue virus NS1 antigen; Dengue virus group specific IgM antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Helicobacter pylori | ||
| Strongyloides spp. | ||
| Hepatitis C virus antibody (anti-HCV) | ||
| Hepatitis A virus (HAV); Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus (HBV); Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Quantitative; Hepatitis C virus (HCV); Human immunodeficiency virus (HIV); Human immunodeficiency virus (HIV) p24 antigen | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | ||
| Dengue virus | ||
| Syphilis Treponema pallidum antibody |
Newborn Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2025
Last Activity Date
11 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2907
Site No.
2900
Print date
24 Nov 2024
END OF SCOPE